Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

To streamline early discovery, a cross-disciplinary, data-driven workflow process is key

Posted on February 23rd, 2018 by

Pharma R&D

laboratory-2815641_1280

“Complex” is the term that best describes the conditions that affect us. Whether it’s a disease or a consequence of a natural process such as aging, there are no simple fixes. Continue reading “To streamline early discovery, a cross-disciplinary, data-driven workflow process is key” »

Introducing the Hive’s newest class of innovative start-ups

Posted on February 14th, 2018 by

The Hive

The hive

In 2017, Elsevier introduced a new program called The Hive, an innovation initiative for biotech and pharmaceutical start-ups committed to promoting collaboration and inspiration across the Pharma & Life Sciences industry.

Continue reading “Introducing the Hive’s newest class of innovative start-ups” »

Harnessing big data — it’s challenging, but it can be done

Posted on February 12th, 2018 by

Pharma R&D

Rubius logo

Today’s big data has the power to drive innovation in ways that the pharmaceutical industry could previously only dream of. Yet harnessing that power comes with an equally sizable challenge: it will require an enormous shift in how research is performed. Continue reading “Harnessing big data — it’s challenging, but it can be done” »

In pharmacovigilance, effective search strings are key

Posted on February 9th, 2018 by

Pharmacovigilance

database-search-2797375_1280

A key component of any pharmacovigilance strategy is building search strings that successfully identify potential adverse events, which must be reported to regulatory agencies. If the query returns too narrow a result set, adverse events may be missed. Continue reading “In pharmacovigilance, effective search strings are key” »

Pharma’s Path to Adopting AI and Other Emerging Technologies

Posted on February 7th, 2018 by

Pharma R&D

create-3026190_1920

Right now in the pharmaceutical space, emerging technologies are dominating the conversation. As the cost of drug development soars, and the potential for success seems more and more elusive, the industry is pinning its hopes on promising technological breakthroughs. Continue reading “Pharma’s Path to Adopting AI and Other Emerging Technologies” »

Drug Development Insights from the 36th Annual J.P. Morgan Healthcare Conference

Posted on January 19th, 2018 by

Pharma R&D

frequency-309372_1280

The 2018 J.P. Morgan Healthcare Conference, held in San Francisco from January 8-11, came and went in a whirlwind. Continue reading “Drug Development Insights from the 36th Annual J.P. Morgan Healthcare Conference” »

  1. 1
  2. 2
  3. 3
  4. 54


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.